Literature DB >> 11330682

Inhibition of telomerase activity by fungus metabolites, CRM646-A and thielavin B.

K Togashi1, H R Ko, J S Ahn, H Osada.   

Abstract

We performed a screening program to identify telomerase inhibitors from our drug source obtained from fungus fermentations, and found that two compounds, CRM646-A and thielavin B, inhibited telomerase activity at doses of 3.2 and 32 microM, respectively. These compounds also inhibited the activity of viral reverse transcriptase at almost the same dose levels which inhibited telomerase activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11330682     DOI: 10.1271/bbb.65.651

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  3 in total

Review 1.  Human telomerase inhibitors from microbial source.

Authors:  Kalarikkal Gopikrishnan Kiran; Muthusamy Palaniswamy; Jayaraman Angayarkanni
Journal:  World J Microbiol Biotechnol       Date:  2015-07-01       Impact factor: 3.312

Review 2.  Telomerase as a Cancer Target. Development of New Molecules.

Authors:  D L Mengual Gomez; R G Armando; C S Cerrudo; P D Ghiringhelli; D E Gomez
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

3.  Thielavins W-Z₇, New Antifouling Thielavins from the Marine-Derived Fungus Thielavia sp. UST030930-004.

Authors:  Zhuang Han; Yong-Xin Li; Ling-Li Liu; Liang Lu; Xian-Rong Guo; Xi-Xiang Zhang; Xiao-Yong Zhang; Shu-Hua Qi; Ying Xu; Pei-Yuan Qian
Journal:  Mar Drugs       Date:  2017-04-29       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.